1. Home
  2. AURA vs RMNI Comparison

AURA vs RMNI Comparison

Compare AURA & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • RMNI
  • Stock Information
  • Founded
  • AURA 2007
  • RMNI 2005
  • Country
  • AURA United States
  • RMNI United States
  • Employees
  • AURA N/A
  • RMNI N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • RMNI Business Services
  • Sector
  • AURA Health Care
  • RMNI Consumer Discretionary
  • Exchange
  • AURA Nasdaq
  • RMNI Nasdaq
  • Market Cap
  • AURA 396.8M
  • RMNI 414.5M
  • IPO Year
  • AURA 2021
  • RMNI N/A
  • Fundamental
  • Price
  • AURA $5.49
  • RMNI $3.79
  • Analyst Decision
  • AURA Strong Buy
  • RMNI Strong Buy
  • Analyst Count
  • AURA 5
  • RMNI 3
  • Target Price
  • AURA $21.80
  • RMNI $5.67
  • AVG Volume (30 Days)
  • AURA 232.9K
  • RMNI 353.0K
  • Earning Date
  • AURA 11-13-2025
  • RMNI 10-30-2025
  • Dividend Yield
  • AURA N/A
  • RMNI N/A
  • EPS Growth
  • AURA N/A
  • RMNI N/A
  • EPS
  • AURA N/A
  • RMNI 0.47
  • Revenue
  • AURA N/A
  • RMNI $425,959,000.00
  • Revenue This Year
  • AURA N/A
  • RMNI N/A
  • Revenue Next Year
  • AURA N/A
  • RMNI $3.12
  • P/E Ratio
  • AURA N/A
  • RMNI $8.07
  • Revenue Growth
  • AURA N/A
  • RMNI N/A
  • 52 Week Low
  • AURA $4.35
  • RMNI $1.84
  • 52 Week High
  • AURA $9.79
  • RMNI $5.38
  • Technical
  • Relative Strength Index (RSI)
  • AURA 41.61
  • RMNI 34.83
  • Support Level
  • AURA $5.18
  • RMNI $3.76
  • Resistance Level
  • AURA $5.87
  • RMNI $4.11
  • Average True Range (ATR)
  • AURA 0.27
  • RMNI 0.22
  • MACD
  • AURA -0.02
  • RMNI -0.03
  • Stochastic Oscillator
  • AURA 25.48
  • RMNI 29.28

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.

Share on Social Networks: